Is Compounded Semaglutide Safe? What LegitScript Certification Actually Means

With hundreds of telehealth platforms offering compounded GLP-1 medications, it is completely understandable to ask: is this safe? Is this legitimate? The honest answer depends entirely on who is providing the medication, which pharmacy is filling it, and what verification systems are in place. Here is what to look for — and what CoraDoc’s certifications actually mean.

What Is Compounded Semaglutide?

Compounded Semaglutide is not FDA-approved. This is important to understand clearly: it has not undergone the FDA’s review process for safety, effectiveness, or quality as a finished drug product. It is prepared by a licensed compounding pharmacy — a 503A traditional pharmacy or a 503B outsourcing facility — using semaglutide as the active pharmaceutical ingredient, dispensed only with a valid individual prescription. This is different from a generic drug. Compounded drugs are not the same as branded medications like Ozempic or Wegovy. The FDA has issued warning letters to telehealth companies that imply otherwise.

What Does LegitScript Certification Mean?

LegitScript is an independent third-party verification service that reviews and certifies telehealth platforms and online pharmacies against a rigorous set of pharmacy practice standards and legal requirements. LegitScript certification means the platform has been reviewed and verified to operate in compliance with applicable laws and pharmacy standards. CoraDoc is LegitScript-certified. You can independently verify this at legitscript.com. LegitScript certification does not verify the compounded drug itself — it verifies the platform operating the telehealth service.

What Is a 503A Compounding Pharmacy?

A 503A compounding pharmacy is a traditional state-licensed compounding pharmacy that prepares medications for individual patients based on a valid prescription. Under Section 503A of the Federal Food, Drug, and Cosmetic Act, these pharmacies are exempt from certain FDA drug approval requirements but must comply with state pharmacy board regulations and federal law. CoraDoc’s pharmacy partner DIRX is a 503A-compliant licensed U.S. compounding pharmacy. Certificates of Analysis verifying the purity and potency of your medication are available upon request.

What Are the Red Flags to Avoid?

When evaluating any compounded GLP-1 provider, avoid platforms that:

• Claim their compounded product is FDA-approved
• Describe it as the same as or equivalent to Ozempic or Wegovy
• Cannot name their compounding pharmacy or provide Certificates of Analysis
• Do not require a licensed provider consultation before prescribing
• Advertise specific weight loss amounts as guaranteed results
• Have no verifiable LegitScript or pharmacy accreditation

The FDA issued warning letters to 30 telehealth companies in February 2026 specifically for making misleading claims about compounded GLP-1 products. (Source: FDA Press Release, March 3, 2026. FDA.gov)

How CoraDoc Verifies Quality

CoraDoc’s quality verification approach includes:

• LegitScript platform certification — independently verified
• Exclusive pharmacy partnership with DIRX — a licensed 503A-compliant U.S. compounding pharmacy
• Certificates of Analysis required for all medications
• Licensed U.S. physicians and nurse practitioners for all prescribing — never an automated algorithm
• Honest claims — we never represent compounded medications as FDA-approved or equivalent to branded drugs

Your safety depends on the provider you choose. CoraDoc’s commitment to transparency means you can verify every claim we make.